Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect
Gabriel N. Maine, Kriselle Maris Lao, Subhashree Mallika Krishnan, et al.
Journal of Clinical Virology (2020) Vol. 133, pp. 104663-104663
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection
Jan Van Elslande, Matthijs Oyaert, Scott Ailliet, et al.
Journal of Clinical Virology (2021) Vol. 136, pp. 104765-104765
Open Access | Times Cited: 136
Association of Disease-Modifying Treatment and Anti-CD20 Infusion Timing With Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple Sclerosis
Giulio Disanto, Rosaria Sacco, Enos Bernasconi, et al.
JAMA Neurology (2021) Vol. 78, Iss. 12, pp. 1529-1529
Open Access | Times Cited: 106
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing
Mary K. Hayden, Ibrahim K El Mikati, Kimberly E. Hanson, et al.
Clinical Infectious Diseases (2024)
Open Access | Times Cited: 62
Follow-up study on COVID-19 survivors one year after discharge from hospital
Yumiao Zhao, Chunxia Yang, Xiaocai An, et al.
International Journal of Infectious Diseases (2021) Vol. 112, pp. 173-182
Open Access | Times Cited: 78
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals
Alessandra Ruggiero, Chiara Piubelli, Lucia Calciano, et al.
EBioMedicine (2022) Vol. 77, pp. 103888-103888
Open Access | Times Cited: 54
Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19
Tamás Pongrácz, Jan Nouta, Wenjun Wang, et al.
EBioMedicine (2022) Vol. 78, pp. 103957-103957
Open Access | Times Cited: 52
IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection
Hari Ram Choudhary, Debaprasad Parai, Girish Chandra Dash, et al.
Infection (2021) Vol. 49, Iss. 5, pp. 1045-1048
Open Access | Times Cited: 53
A Pilot Study for the Evaluation of an Interferon Gamma Release Assay (IGRA) To Measure T-Cell Immune Responses after SARS-CoV-2 Infection or Vaccination in a Unique Cloistered Cohort
Pablo Barreiro, Juan Carlos Sanz, Jesús San Román, et al.
Journal of Clinical Microbiology (2022) Vol. 60, Iss. 3
Open Access | Times Cited: 35
Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State–wide Psychiatric Hospital System
Katlyn Nemani, Sharifa Z. Williams, Mark Olfson, et al.
JAMA Network Open (2022) Vol. 5, Iss. 5, pp. e2210743-e2210743
Open Access | Times Cited: 29
Kinetics of specific anti-SARS-CoV-2 IgM, IgA, and IgG responses during the first 12 months after SARS-CoV-2 infection: A prospective longitudinal study
Houda Amellal, Najlaa Assaid, Hicham Charoute, et al.
PLoS ONE (2023) Vol. 18, Iss. 7, pp. e0288557-e0288557
Open Access | Times Cited: 17
Antibody Responses to mRNA COVID-19 Vaccine Among Healthcare Workers in Outpatient Clinics in Japan
Teruhime Otoguro, Keita Wagatsuma, Teruko Hino, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 90-90
Open Access
The demography and characteristics of SARS-CoV-2 seropositive residents and staff of nursing homes for older adults in the Community of Madrid: the SeroSOS study
Francisco Javier Candel, Pablo Barreiro, Jesús San Román, et al.
Age and Ageing (2021) Vol. 50, Iss. 4, pp. 1038-1047
Open Access | Times Cited: 31
COVID-19 vaccination immune paresis in heart and lung transplantation
Saima Aslam, Lara Danziger‐Isakov, Mandeep R. Mehra
The Journal of Heart and Lung Transplantation (2021) Vol. 40, Iss. 8, pp. 763-766
Open Access | Times Cited: 30
Comparison of SARS-CoV-2 antibody response after two doses of mRNA and inactivated vaccines in multiple sclerosis patients treated with disease-modifying therapies
Serkan Özakbaş, Cavid Baba, Yavuz Doğan, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 58, pp. 103486-103486
Open Access | Times Cited: 21
Immune Determinants of Viral Clearance in Hospitalised COVID-19 Patients: Reduced Circulating Naïve CD4+ T Cell Counts Correspond with Delayed Viral Clearance
Mihaela Zlei, Igor A. Sidorov, Simone A. Joosten, et al.
Cells (2022) Vol. 11, Iss. 17, pp. 2743-2743
Open Access | Times Cited: 20
Longitudinal Postvaccine SARS-CoV-2 Immunoglobulin G Titers, Memory B-Cell Responses, and Risk of COVID-19 in Multiple Sclerosis Over 1 Year
Giulio Disanto, Alice Galante, Marco Cantu', et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 20
Variation in antibody titers determined by Abbott and Roche Elecsys SARS-CoV-2 assays in vaccinated healthcare workers
Miku Nakai, Daisuke Yokoyama, Tomoaki Sato, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e16547-e16547
Open Access | Times Cited: 10
A Systematic Review and Meta-Analysis of the Sensitivity of Antibody Tests for the Laboratory Confirmation of COVID-19
Makoah N. Aminake, Thomas Tipih, Matefo M Litabe, et al.
Future Virology (2021) Vol. 17, Iss. 2, pp. 119-139
Open Access | Times Cited: 21
Persistence of humoral response upon SARS‐CoV‐2 infection
Andrea Knies, Dennis Ladage, Ralf J. Braun, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 18
Sustained Antibody-Dependent NK Cell Functions in Mild COVID-19 Outpatients During Convalescence
Francisco Fuentes‐Villalobos, José Luis Velasco Garrido, Matías A. Medina, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Investigating the Seroconversion Patterns of Specific Antibodies Against Various Antigens of SARS-CoV-2 in Hospitalized COVID-19 Patients and Vaccinated Individuals
Shahrzad Matinfar, Sahar Mortezagholi, darya amiri, et al.
Archives of Clinical Infectious Diseases (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Practical guidance for clinical laboratories for SARS-CoV-2 serology testing
Carmen Charlton, Jamil N. Kanji, Vanessa Tran, et al.
Canada Communicable Disease Report (2021) Vol. 47, Iss. 04, pp. 171-183
Open Access | Times Cited: 16
Clinical and analytical evaluation of the Abbott AdviseDx quantitative SARS-CoV-2 IgG assay and comparison with two other serological tests
Gabriel N. Maine, Subhashree Mallika Krishnan, Kelly Walewski, et al.
Journal of Immunological Methods (2022) Vol. 503, pp. 113243-113243
Open Access | Times Cited: 11
Multicentre Performance Evaluation of the Elecsys Anti-SARS-CoV-2 Immunoassay as an Aid in Determining Previous Exposure to SARS-CoV-2
Elena Riester, Mario Majchrzak, A. Mühlbacher, et al.
Infectious Diseases and Therapy (2021) Vol. 10, Iss. 4, pp. 2381-2397
Open Access | Times Cited: 15
COVID-19 IgG/IgM patterns, early IL-6 elevation and long-term radiological sequelae in 75 patients hospitalized due to interstitial pneumonia followed up from 3 to 12 months
Domenico Maurizio Toraldo, Francesco Satriano, R Rollo, et al.
PLoS ONE (2022) Vol. 17, Iss. 2, pp. e0262911-e0262911
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top